230 related articles for article (PubMed ID: 25500827)
21. Near-Infrared Photoimmunotherapy of Cancer.
Kobayashi H; Choyke PL
Acc Chem Res; 2019 Aug; 52(8):2332-2339. PubMed ID: 31335117
[TBL] [Abstract][Full Text] [Related]
22. Trastuzumab-based near-infrared photoimmunotherapy in xenograft mouse of breast cancer.
Yamashita S; Kojima M; Onda N; Yoshida T; Shibutani M
Cancer Med; 2023 Feb; 12(4):4579-4589. PubMed ID: 36259134
[TBL] [Abstract][Full Text] [Related]
23. Applying near-infrared photoimmunotherapy to B-cell lymphoma: comparative evaluation with radioimmunotherapy in tumor xenografts.
Heryanto YD; Hanaoka H; Nakajima T; Yamaguchi A; Tsushima Y
Ann Nucl Med; 2017 Nov; 31(9):669-677. PubMed ID: 28741052
[TBL] [Abstract][Full Text] [Related]
24. A Novel Theranostic Combination of Near-infrared Fluorescence Imaging and Laser Irradiation Targeting c-KIT for Gastrointestinal Stromal Tumors.
Fujimoto S; Muguruma N; Okamoto K; Kurihara T; Sato Y; Miyamoto Y; Kitamura S; Miyamoto H; Taguchi T; Tsuneyama K; Takayama T
Theranostics; 2018; 8(9):2313-2328. PubMed ID: 29721082
[TBL] [Abstract][Full Text] [Related]
25. Near infrared photoimmunotherapy targeting DLL3 for small cell lung cancer.
Isobe Y; Sato K; Nishinaga Y; Takahashi K; Taki S; Yasui H; Shimizu M; Endo R; Koike C; Kuramoto N; Yukawa H; Nakamura S; Fukui T; Kawaguchi K; Chen-Yoshikawa TF; Baba Y; Hasegawa Y
EBioMedicine; 2020 Feb; 52():102632. PubMed ID: 31981983
[TBL] [Abstract][Full Text] [Related]
26. Immediate in vivo target-specific cancer cell death after near infrared photoimmunotherapy.
Mitsunaga M; Nakajima T; Sano K; Kramer-Marek G; Choyke PL; Kobayashi H
BMC Cancer; 2012 Aug; 12():345. PubMed ID: 22873679
[TBL] [Abstract][Full Text] [Related]
27. Selection of antibody and light exposure regimens alters therapeutic effects of EGFR-targeted near-infrared photoimmunotherapy.
Okada R; Kato T; Furusawa A; Inagaki F; Wakiyama H; Fujimura D; Okuyama S; Furumoto H; Fukushima H; Choyke PL; Kobayashi H
Cancer Immunol Immunother; 2022 Aug; 71(8):1877-1887. PubMed ID: 35013765
[TBL] [Abstract][Full Text] [Related]
28. Near-infrared photoimmunotherapy (NIR-PIT) on cholangiocarcinoma using a novel catheter device with light emitting diodes.
Hirata H; Kuwatani M; Nakajima K; Kodama Y; Yoshikawa Y; Ogawa M; Sakamoto N
Cancer Sci; 2021 Feb; 112(2):828-838. PubMed ID: 33345417
[TBL] [Abstract][Full Text] [Related]
29. Characterization of Site-Specifically Conjugated Monomethyl Auristatin E- and Duocarmycin-Based Anti-PSMA Antibody-Drug Conjugates for Treatment of PSMA-Expressing Tumors.
Lütje S; Gerrits D; Molkenboer-Kuenen JD; Herrmann K; Fracasso G; Colombatti M; Boerman OC; Heskamp S
J Nucl Med; 2018 Mar; 59(3):494-501. PubMed ID: 29146698
[TBL] [Abstract][Full Text] [Related]
30. Near infrared photoimmunotherapy with avelumab, an anti-programmed death-ligand 1 (PD-L1) antibody.
Nagaya T; Nakamura Y; Sato K; Harada T; Choyke PL; Hodge JW; Schlom J; Kobayashi H
Oncotarget; 2017 Jan; 8(5):8807-8817. PubMed ID: 27716622
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic imaging in near-infrared photoimmunotherapy using a commercially available camera for indocyanine green.
Inagaki FF; Fujimura D; Furusawa A; Okada R; Wakiyama H; Kato T; Choyke PL; Kobayashi H
Cancer Sci; 2021 Mar; 112(3):1326-1330. PubMed ID: 33543819
[TBL] [Abstract][Full Text] [Related]
32. Epidermal Growth Factor Receptor (EGFR)-targeted Photoimmunotherapy (PIT) for the Treatment of EGFR-expressing Bladder Cancer.
Railkar R; Krane LS; Li QQ; Sanford T; Siddiqui MR; Haines D; Vourganti S; Brancato SJ; Choyke PL; Kobayashi H; Agarwal PK
Mol Cancer Ther; 2017 Oct; 16(10):2201-2214. PubMed ID: 28619755
[TBL] [Abstract][Full Text] [Related]
33. Near infrared photoimmunotherapy with an anti-mesothelin antibody.
Nagaya T; Nakamura Y; Sato K; Zhang YF; Ni M; Choyke PL; Ho M; Kobayashi H
Oncotarget; 2016 Apr; 7(17):23361-9. PubMed ID: 26981775
[TBL] [Abstract][Full Text] [Related]
34. Near-infrared photoimmunotherapy: a comparison of light dosing schedules.
Ogata F; Nagaya T; Nakamura Y; Sato K; Okuyama S; Maruoka Y; Choyke PL; Kobayashi H
Oncotarget; 2017 May; 8(21):35069-35075. PubMed ID: 28456784
[TBL] [Abstract][Full Text] [Related]
35. MRP1-targeted near infrared photoimmunotherapy for drug resistant small cell lung cancer.
Li F; Mao C; Yeh S; Sun Y; Xin J; Shi Q; Ming X
Int J Pharm; 2021 Jul; 604():120760. PubMed ID: 34077781
[TBL] [Abstract][Full Text] [Related]
36. Near-infrared theranostic photoimmunotherapy (PIT): repeated exposure of light enhances the effect of immunoconjugate.
Mitsunaga M; Nakajima T; Sano K; Choyke PL; Kobayashi H
Bioconjug Chem; 2012 Mar; 23(3):604-9. PubMed ID: 22369484
[TBL] [Abstract][Full Text] [Related]
37. PSMA-reactive NB7 single domain antibody fragment: A potential scaffold for developing prostate cancer theranostics.
Huynh TT; Feng Y; Meshaw R; Zhao XG; Rosenfeld L; Vaidyanathan G; Papo N; Zalutsky MR
Nucl Med Biol; 2024; 134-135():108913. PubMed ID: 38703588
[TBL] [Abstract][Full Text] [Related]
38. The feasibility of Miltuximab®-IRDye700DX-mediated photoimmunotherapy of solid tumors.
Polikarpov DM; Campbell DH; Lund ME; Lu Y; Lu Y; Wu J; Walsh BJ; Zvyagin AV; Gillatt DA
Photodiagnosis Photodyn Ther; 2020 Dec; 32():102064. PubMed ID: 33069874
[TBL] [Abstract][Full Text] [Related]
39. Cadherin-17 Targeted Near-Infrared Photoimmunotherapy for Treatment of Gastrointestinal Cancer.
Lum YL; Luk JM; Staunton DE; Ng DKP; Fong WP
Mol Pharm; 2020 Oct; 17(10):3941-3951. PubMed ID: 32931292
[TBL] [Abstract][Full Text] [Related]
40. Cancer neovasculature-targeted near-infrared photoimmunotherapy (NIR-PIT) for gastric cancer: different mechanisms of phototoxicity compared to cell membrane-targeted NIR-PIT.
Nishimura T; Mitsunaga M; Ito K; Kobayashi H; Saruta M
Gastric Cancer; 2020 Jan; 23(1):82-94. PubMed ID: 31302791
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]